Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Semaglutide Peptide for Weight Loss | American Male Wellness

The Semglutide Peptide was approved by the FDA in 2021. American Male Wellness is proud to offer a new Semaglutide Peptide Therapy in Las Vegas. American Male Wellness Semaglutide Peptide Therapy has been shown with proven results to help those with obesity and diabetes by helping to reduce appetite and control cravings. The AMW clinic was able to reverse type 2 diabetes and pre-diabetes situations in patients within 3-6 months.


News provided by

American Male Wellness

Feb 11, 2022, 18:05 ET

Share this article

Share toX

Share this article

Share toX

Semaglutide Peptide for Weight Loss | American Male Wellness
Semaglutide Peptide for Weight Loss | American Male Wellness

LAS VEGAS, February 11, 2022 /PRNewswire-PRWeb/ -- The Semglutide Peptide was approved by the FDA in 2021. American Male Wellness is proud to offer a new Semaglutide Peptide Therapy in Las Vegas.
American Male Wellness Semaglutide Peptide Therapy has been shown with proven results to help those with obesity and diabetes by helping to reduce appetite and control cravings. The AMW clinic was able to reverse type 2 diabetes and pre-diabetes situations in patients within 3-6 months.

This miracle peptide was initially discovered and used by patients with Type 2 diabetes and pre-diabetes. Although in later research it was discovered that the Semaglutide peptide had a great impact on weight loss contribution in a more natural way and patients were able to lose up to 10% of body fat within 1 year. These patients were able to sustain the results and Semaglutide is becoming more available for everyone and not limited only to people with diabetes.

It will help those individuals suffering from diabetes and weight issues regain control over their health and lifestyle. - Dr. Tam | American Male Wellness

Post this

American Male Wellness is offering a groundbreaking therapy for diabetes and weight loss candidates through the use of Semaglutide Peptides, which was approved for use by the FDA in 2021. American Male Wellness is a leading men's and women's health clinic in Las Vegas providing a number of holistic and natural therapies. Semaglutide Peptide Therapy has been shown to help those with obesity and diabetes by helping to reduce appetite and control cravings.

Having trouble managing diabetes - The Semaglutide peptide works by stimulating insulin secretion, suppressing appetite, and increasing satiety (fullness after eating).

These effects are the result of the actions on GLP-1 receptors in the GI tract which help regulate blood glucose levels as well as suppress appetite.
Peptide Therapy: A Natural Alternative for Diabetes Treatment

American Male Wellness provides patients with a significant level of care and understanding that is not available anywhere else in Las Vegas. The use of Semaglutide Peptides is providing hope for those who suffer from obesity as well as those looking to manage their diabetes. Those interested in receiving therapy should contact American Male Wellness to learn more about treatment options.

"We are excited to be able to offer this therapy at our clinic," said Dr. Tam. "It will help those individuals suffering from diabetes and weight issues regain control over their health and lifestyle."

Semaglutide Peptide Therapy is a commonly used treatment for obesity and Type 2 diabetes that has been shown to help those with weight loss by helping to reduce appetite and control cravings. In addition, the therapy can lead to improved blood sugar levels as well as a decrease in common symptoms of diabetes such as excessive thirst, hunger, urination, fatigue, blurry vision, and irritability.

American Male Wellness is proud to offer Semaglutide Peptide Therapy in Las Vegas

The therapy requires two injections per week over the course of 12 weeks, and it has been shown to help patients lose 6-8% of their weight. This means that after 12 weeks on the program, an obese patient could potentially lose up to 18 pounds or more. Patients who complete all 24 weeks can expect to see an average total weight loss of about 20 pounds.

Benefits of Semaglutide Peptides:

  • Lose weight
  • Lowers blood pressure
  • Lowers blood sugar
  • Lowers cholesterol
  • Manages cardiovascular health
  • Easy to implement in your medication plan

American Male Wellness is the best male clinic in Las Vegas that combines the latest medical breakthroughs with traditional, natural therapies to achieve unprecedented results in a safe and private healing environment.

We provide leading-edge treatments such as Erectile Dysfunction, Testosterone Replacement, Peptide Therapy, and much more!

Media Contact

Eytan, American Male Wellness, 1 (702) 347-7000, [email protected]

Dr. Kenneth Tam, American Male Wellness, (702) 347-7000, [email protected]

SOURCE American Male Wellness

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.